Economic Evaluation of Exome and Genome Sequencing in Child Health

October 15, 2020, 12:00 pm -1:00 pm EDT

Join us for a free webinar

Wendy Ungar

Wendy Ungar, PhD
Senior Scientist,
Child Health Evaluative Sciences,
Hospital for Sick Children Research Institute,
Professor, Institute of Health Policy, Management and Evaluation,
University of Toronto,
Ontario, Canada

As whole exome sequencing (WES) and whole genome sequencing (WGS) technologies are increasingly used in clinical practice, there is a pressing need to understand the true costs of these technologies as well as their incremental cost-effectiveness compared to standard approaches to genetic testing. This seminar will present research delineating the costs of various WES and WGS platforms, and the use of these estimates in evaluations of sequencing technologies for diagnosing autism spectrum disorder, unexplained developmental disabilities, and multiple congenital anomalies. The mechanism for using economic evidence to inform funding of genomic technologies will be briefly explained.

Hosted by

  • CDC Health Economics Research Group (HERG)
  • Office of Genomics and Precision Public Health, Office of Science
Page last reviewed: August 10, 2020